Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regeneron Pharmaceuticals Inc (REGN)  
$985.02 4.45 (0.45%) as of 4:30 Fri 5/24


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 104,690,000
Market Cap: 103.12(B)
Last Volume: 259,279 Avg Vol: 765,410
52 Week Range: $692.45 - $993.95
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  150
Guru Rank Value     : 6.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 168,566 236,471 279,472 438,206
Total Sell Value $164,437,486 $226,505,895 $262,153,799 $373,147,368
Total People Sold 8 14 16 18
Total Sell Transactions 15 42 60 120
End Date 2024-02-25 2023-11-24 2023-05-26 2022-05-26

   
Records found: 1366
  Page 25 of 55  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Ryan Arthur F Director   –       •      –    2020-12-01 4 AS $515.64 $52,048 D/D (100) 23,643 -7%     
   Vagelos P Roy Director   –       •      –    2020-11-19 4 GA $0.00 $0 I/I 2,406 3,609     -
   Vagelos P Roy Director   –       •      –    2020-11-19 4 GD $0.00 $0 I/I 2,406 47,786     -
   Murphy Andrew J EVP Research   •       –      –    2020-11-17 4 AS $536.68 $3,597,188 D/D (6,628) 47,136 -13%     
   Murphy Andrew J EVP Research   •       –      –    2020-11-16 4 D $561.39 $3,990,360 D/D (7,108) 53,764     -
   Murphy Andrew J EVP Research   •       –      –    2020-11-16 4 OE $30.63 $420,734 D/D 13,736 60,872     -
   Coles N Anthony Director   –       •      –    2020-11-13 4 OE $345.47 $3,800 D/D 11 654     -
   Ryan Arthur F Director   –       •      –    2020-11-02 4 AS $544.54 $54,854 D/D (100) 23,743 -12%     
   Murphy Andrew J EVP Research   •       –      –    2020-10-22 4 OE $30.63 $199,926 D/D 5,185 47,136     -
   Vagelos P Roy Director   –       •      –    2020-10-06 4 GD $0.00 $0 I/I 349 143,210     -
   Mccourt Marion SVP Commercial   •       –      –    2020-10-05 4 AS $600.00 $600,000 D/D (1,000) 13,963 -21%     
   Mccourt Marion SVP Commercial   •       –      –    2020-10-05 4 OE $342.93 $342,930 D/D 1,000 14,963     -
   Goldstein Joseph L Director   –       •      –    2020-10-05 4 AS $600.00 $5,527,200 D/D (9,212) 5,643 -21%     
   Goldstein Joseph L Director   –       •      –    2020-10-05 4 OE $520.01 $4,790,332 D/D 9,212 14,855     -
   Ryan Arthur F Director   –       •      –    2020-10-01 4 AS $553.73 $55,813 D/D (100) 28,343 -14%     
   Fenimore Christopher R. VP Controller   •       –      –    2020-09-24 4 GA $0.00 $0 I/I 50 25     -
   Fenimore Christopher R. VP Controller   •       –      –    2020-09-24 4 GD $0.00 $0 I/I 50 0     -
   Brown Michael S Director   –       •      –    2020-09-22 4 AS $552.36 $552,360 I/I (1,000) 9,349 -14%     
   Brown Michael S Director   –       •      –    2020-09-22 4 AS $552.36 $2,811,512 D/D (5,090) 643 -14%     
   Brown Michael S Director   –       •      –    2020-09-22 4 OE $376.69 $1,927,917 D/D 5,090 5,733     -
   Goldstein Joseph L Director   –       •      –    2020-09-22 4 AS $552.36 $11,047 D/D (20) 5,643 -14%     
   Goldstein Joseph L Director   –       •      –    2020-09-21 4 AS $543.19 $9,102,446 D/D (16,554) 5,663 -10%     
   Goldstein Joseph L Director   –       •      –    2020-09-21 4 OE $371.40 $6,244,372 D/D 16,574 22,217     -
   Ryan Arthur F Director   –       •      –    2020-09-01 4 AS $591.50 $60,458 D/D (100) 28,443 -14%     
   Larosa Joseph J EVP General Counsel and Secret   •       –      –    2020-08-31 4 S $615.04 $2,873,467 D/D (4,672) 14,438 18%     
  1366 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 25 of 55
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us